Astrazeneca Plc Adr Stock Price on April 15, 2024
| AZN Stock | USD 75.43 0.26 0.35% |
Below is the normalized historical share price chart for AstraZeneca PLC ADR extending back to May 12, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of AstraZeneca PLC stands at 75.43, as last reported on the 29th of April, with the highest price reaching 75.49 and the lowest price hitting 74.59 during the day.
If you're considering investing in AstraZeneca Stock, it is important to understand the factors that can impact its price. AstraZeneca PLC appears to be very steady, given 3 months investment horizon. AstraZeneca PLC ADR secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for AstraZeneca PLC ADR, which you can use to evaluate the volatility of the firm. Please makes use of AstraZeneca PLC's Downside Deviation of 1.34, risk adjusted performance of 0.1027, and Mean Deviation of 0.9473 to double-check if our risk estimates are consistent with your expectations.
At this time, AstraZeneca PLC's Total Stockholder Equity is very stable compared to the past year. As of the 29th of April 2024, Liabilities And Stockholders Equity is likely to grow to about 106.2 B, while Common Stock Shares Outstanding is likely to drop about 2.9 B. . At this time, AstraZeneca PLC's Price Cash Flow Ratio is very stable compared to the past year. As of the 29th of April 2024, Price Fair Value is likely to grow to 9.53, while Price To Sales Ratio is likely to drop 2.62. AstraZeneca Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of May 1993 | 200 Day MA 66.8006 | 50 Day MA 67.1698 | Beta 0.19 |
AstraZeneca |
Sharpe Ratio = 0.1494
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AZN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.42 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average AstraZeneca PLC is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AstraZeneca PLC by adding it to a well-diversified portfolio.
Price Book 5.4598 | Enterprise Value Ebitda 17.7384 | Price Sales 4.6651 | Shares Float 1.5 B | Dividend Share 2.9 |
Related Headline
Walmart Headline on 15th of April 2024
Trump Medias Stock Dips 15 percent Amid News of Potential Sh... by gurufocus.com
On Monday, the stock value of the company behind Truth Social, owned by Donald Trump, experienced a 15 percent decrease. This decline is part of a continuing trend sin
AstraZeneca PLC Valuation on April 15, 2024
It is possible to determine the worth of AstraZeneca PLC on a given historical date. On April 15, 2024 AstraZeneca was worth 69.07 at the beginning of the trading date compared to the closed value of 68.73. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of AstraZeneca PLC stock. Still, in general, we apply an absolute valuation method to find AstraZeneca PLC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of AstraZeneca PLC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against AstraZeneca PLC's related companies.
| Open | High | Low | Close | Volume | |
| 69.66 | 69.82 | 68.60 | 68.93 | 9,121,408 | |
04/15/2024 | 69.07 | 69.56 | 68.54 | 68.73 | 9,213,527 |
| 68.29 | 68.60 | 68.02 | 68.27 | 5,361,980 |
| Backtest AstraZeneca PLC | | | AstraZeneca PLC History | | | AstraZeneca PLC Valuation | Previous | Next |
AstraZeneca PLC Trading Date Momentum on April 15, 2024
| On April 16 2024 AstraZeneca PLC ADR was traded for 68.27 at the closing time. Highest AstraZeneca PLC's price during the trading hours was 68.60 and the lowest price during the day was 68.02 . The net volume was 5.4 M. The overall trading history on the 16th of April 2024 contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 0.67% . The overall trading delta to current price is 9.11% . |
AstraZeneca PLC ADR Fundamentals Correlations and Trends
By evaluating AstraZeneca PLC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among AstraZeneca PLC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. AstraZeneca financial account trend analysis is a perfect complement when working with valuation or volatility modules.About AstraZeneca PLC Stock history
AstraZeneca PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AstraZeneca is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AstraZeneca PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AstraZeneca PLC stock prices may prove useful in developing a viable investing in AstraZeneca PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.1 B | 2.9 B | |
| Net Income Applicable To Common Shares | 3 B | 3.2 B |
AstraZeneca PLC Stock Technical Analysis
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
AstraZeneca PLC Period Price Range
Low | April 15, 2024
| High |
69.07 | 68.73 |
AstraZeneca PLC April 29, 2024 Market Strength
Market strength indicators help investors to evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By undertsting and applying AstraZeneca PLC stock market strength indicators, traders can identify AstraZeneca PLC ADR entry and exit signals to maximize returns
| Accumulation Distribution | 135103.0 | |||
| Daily Balance Of Power | (0.33) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 69.05 | |||
| Day Typical Price | 68.94 | |||
| Price Action Indicator | (0.49) | |||
| Period Momentum Indicator | 6.7 |
AstraZeneca PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AstraZeneca PLC's price direction in advance. Along with the technical and fundamental analysis of AstraZeneca Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AstraZeneca to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1027 | |||
| Jensen Alpha | 0.1596 | |||
| Total Risk Alpha | 0.03 | |||
| Sortino Ratio | 0.0949 | |||
| Treynor Ratio | 0.3508 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.207 | Dividend Share 2.9 | Earnings Share 2.02 | Revenue Per Share 2.5512 | Quarterly Revenue Growth 0.165 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.